NF-κB has been implicated in the pathogenesis of several inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, systemic lupus erythematosus, type I diabetes, chronic obstructive pulmonary disease and asthma. Here, NFKB1 is linked to inflammatory bowel disease.